Abstract:Background and aim of the study: The study aim was to evaluate the effect of percutaneous balloon mitral valvuloplasty (PBMV) on plasma B-type natriuretic peptide (BNP) levels in patients in sinus rhythm (SR) and with atrial fibrillation (AF).Methods: Thirty patients with rheumatic mitral stenosis who underwent successful PBMV were included in the study. Of these patents, 21 were in SR (SR group) and nine had AF (AF group). Plasma BNP levels were measured using the Triage BNP Test in all patients before, and at 20 min and 24 h after, PBMV. Control levels were measured in eight healthy volunteers.Results: Basal plasma BNP levels in patients were significantly higher than those in controls (123.5 +/- 69.5 versus 16.4 +/- 7.6 pg/ml, p < 0.01), and correlated with mean left atrial pressure (mLAP; r = 0.441, p < 0.05) and pulmonary artery pressure (PAP; r = 0.488, p < 0.01). No significant difference was observed in BNP levels between the SR and AF groups. In the SR group, BNP levels decreased after PBMV (pre-PBMV 128.7 +/- 75.9 pg/ml; at 20 min, 88.6 +/- 62.0 pg/ml; at 24 h, 43.4 +/- 26.7 pg/ml; respectively, p < 0.05). Changes in plasma BNP (Delta BNP) correlated positively with those in mLAP (Delta mLAP) (r = 0.696, p < 0.01) and PAP (APAP) (r = 0.456, p < 0.05). Left ventricular end-diastolic volume (LVEDV) (96.1 +/- 21.6 versus 111.5 +/- 25.2 ml, p < 0.01) and stroke volume (SV) (59.2 +/- 15.8 versus 69.0 +/- 17.9 ml, p < 0.05) augmented accordingly without any changes in left ventricular end-diastolic pressure (LVEDP) (p = NS). In contrast, in group AF, BNP levels remained unchanged (pre-PBMV 111.6 +/- 53.4 pg/ml; at 20 min, 122.0 +/- 68.7 pg/ml; at 24 h, 106.1 +/- 56.2 pg/ml; respectively, p NS), while LVEDP increased (6.4 +/- 3.6 versus 8.6 +/- 3.2 mmHg, p < 0.01), without any changes in LVEDV and SV (p = NS).Conclusion: The study results indicate that, in mitral stenosis patients, a high BNP level is associated with high mLAP and PAP. Cardiac rhythm may play an important role in changes of BNP level after PBMV. BNP may be a valid marker to reflect changes in mLAP and PAP after PBMV in patients with SR, but not in those with AF.

Influence of Atrial Fibrillation Type on Plasma Brain Natriuretic Peptide Level in Male Patients

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

BNP levels and its influencing factors in patients with acute coronary syndrome

Effects of Percutaneous Balloon Mitral Valvuloplasty on Plasma B-type Natriuretic Peptide in Rheumatic Mitral Stenosis with and Without Atrial Fibrillation.

Changes of Plasma B-type Natriuretic Peptide after Percutanouse Balloon Mitral Valvuloplasty

Differential Diagnoses Value of Plasama Brain Natriuretic in Patients with Acute Heart Failure

Study on the Changes of Plasma Levels of Brain natriureticpeptide(BNP) and C-Reactive Protein(CRP) in Patients with Acute Cerebral Infarction

Determinants of N-terminal ProBNP Levels in Patients with Atrial Fibrillation and Preserved Left Ventricular Systolic Function

Effect of atrial fibrillation on plasma NT-proBNP in patients with different cardiac functions PAN

Effects of Percutaneous Balloon Mitrai Valvuloplasty on Plasma B-type Natriuretic Peptide in Rheumatic Mitral Stenosis Patients

The Correlation Of Left Ventricular Remodeling And Plasma Brain Natriuretic Peptide Undergoing Different Reperfusion In Patients With First ST-segment Elevation Acute Anterior Myocardial Infarction 1

Clinical Significance and Level of Blood B NP in Patients with Persistent Atrial Fibrillation before and after Catheter Ablation

Effect of Bradyarrhythmia on the Plasma Levels of N-terminal Pro-Brain Natriuretic Peptide

Clinical significance and changes of plasma brain natriuretic peptide level in patients with chronic obstructive pul monary disease under different conditions

A Study of the Effect of Acute Cerebral Infarction on Left Ventricular Function and the Relationship between Acute Cerebral Infarction and Plasma Brain Natriuretic Peptide

Plasma N-terminal Pro-Brain Natriuretic Peptide Levels Predict New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction

Relationship between Brain Natriuretic Peptide and Thromboembolic Events in Elderly Patients with Nonvalvular Atrial Fibrillation

Plasma Brain Natriuretic Peptide Levels in the Diagnosis of Heart Failure

Study on the Relationship between Spontaneous Cerebral Hemorrhage and Serum B-type Brain Natriuretic Peptide

Clinical Significance of Plasma Cardiac Troponin Ⅰ and Brain Natriuretic Peptide Level Measurements in Different Gender Patients with Angina Pectoris

Clinical Effects of Recombinant Human BNP in Treating Acute Heart Failure and Study on Its Effects on TWEAK and Nt-Pro BNP